SecBot SecBot

CYDY

CytoDyn Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001175680 Biotech & Drug Discovery
$0.2600 +0.02 (+8.33%)
Oct 23 4:00 PM ET · prev $0.2400
1 year
0.0%
from $0.2600 · Oct 24
30 days
+23.8%
from $0.2100
52-week range
$0.1900–0.3700
−30% from high · low Jul 29
Avg volume 20D
2.54M
Oct 20 spike 7.35M
Short interest
36.29M
+0.3%
Days to cover
11.5
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
7
analyzed by SecBot
SecBot read BEARISH 6 reports · 90 days
Balance 4 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 5/6
Strongest BULLISH CytoDyn filed DEFA14A definitive additional proxy soliciting materials, which incorporate an 8-K announcing…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersSTEADY

    Short interest +0.3% to 36.29M shares. 11.5 days to cover.

  • TrendUPTREND

    22% above its 50-day average.

The Street

last action Jul 2020
Recent actions
DateFirmActionRating
Jul 6, 2020HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Apr 28, 2020HC Wainwright & Co.
REITERATE
REITERATEBuy
Apr 3, 2020HC Wainwright & Co.
REITERATE
REITERATEBuy
Dec 19, 2019HC Wainwright & Co.
REITERATE
REITERATEBuy
Sep 16, 2019HC Wainwright & Co.
REITERATE
REITERATEBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 14, 2026
Earnings result
CYDY Q1 2027 Earnings: EPS $-0.01
Oct 8, 2026
Earnings date
CYDY Q1 2027 Earnings Scheduled — 2026-10-08
Aug 10, 2026
Earnings date
CYDY Q4 2026 Earnings Scheduled — 2026-08-10
Jul 23, 2026
Earnings date
CYDY Q4 2026 Earnings Scheduled — 2026-07-23
May 13, 2026
Short interest
FTD: CYDY — 1,785,957 shares ($0.6M) failed to deliver
Settlement: 20260513, Price: $0.35, FTD Value: $625,084.95, CYTODYN, INC.

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Oct 20, 2026
Hoffman Robert E.
Chief Executive Officer
AWARD2,500,000 sh
Mar 20, 2026
Blok Tyler
Chief Legal Officer
AWARD3,249,794 sh
Mar 20, 2026
Hoffman Robert E.
Chief Financial Officer
AWARD4,874,691 sh
Mar 20, 2026
Brunke Karen J
Director
AWARD574,385 sh
Mar 20, 2026
Ndhlovu Lishomwa C
Director
AWARD574,385 sh
Mar 20, 2026
Urbach Tanya Durkee
Director
AWARD574,385 sh
Mar 20, 2026
Lalezari Jacob P
Chief Executive Officer
AWARD4,874,691 sh
Mar 20, 2026
SIMES STEPHEN M
Director
AWARD574,385 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
36,290,827
shares short
+0.3%
vs prior settlement
11.5
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 Insider
Hoffman Robert E. was granted 2,500,000 shares
Chief Executive Officer
Oct 19, 2026 SEC
CytoDyn filed DEFA14A definitive additional proxy soliciting materials, which incorporate an 8-K announcing a CEO…
DEFA14A — Impact 6/10
Oct 19, 2026 SEC
CytoDyn appointed CFO Robert E. Hoffman as CEO effective October 20, 2026, replacing Dr. Jacob Lalezari who…
8-K — Impact 5/10
Oct 14, 2026 Earnings result
CYDY Q1 2027 Earnings: EPS $-0.01
Oct 8, 2026 SEC
The SEC declared CytoDyn's S-3 shelf registration (File No. 333-299150) effective on October 7, 2026. This allows the…
EFFECT — Impact 6/10
Mar 20, 2026 Insider
Blok Tyler was granted 3,249,794 shares
Chief Legal Officer
Mar 20, 2026 Insider
Hoffman Robert E. was granted 4,874,691 shares
Chief Financial Officer

SecBot reports

7 filings · 1 bullish · 5 bearish · 1 neutral
All CYDY filing & press-release reports (7)